Emmanouil M. Xydias

Dr. Emmanouil M. Xydias

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ETElias Tsakos
Elias Tsakos
EXEmmanouil M. Xydias
Emmanouil M. Xydias
Apostolos ZiogasApostolos Ziogas
Apostolos Ziogas
Felice SorrentinoFelice Sorrentino
Felice Sorrentino
LNLuigi Nappi
Luigi Nappi
ANGELOS DANIILIDISANGELOS DANIILIDIS
ANGELOS DANIILIDIS
Background: Uterine fibroids are the most frequently diagnosed gynaecological tumours, and they often require surgical treatment (conventional laparoscopic myomectomy—CLM). The introduction and evolution of robotic-assisted laparoscopic myomectomy (RALM) in the early 2000s has expanded the range of minimally invasive options for the majority of cases. This study aims to compare RALM with CLM and abdominal myomectomy (AM). Methods and materials: Fifty-three eligible studies adhered to the pre-established inclusion criteria and were subsequently evaluated for risk of bias and statistical heterogeneity. Results: The available comparative studies were compared using surgical outcomes, namely blood loss, complication rate, transfusion rate, operation duration, conversion to laparotomy, and length of hospitalisation. RALM was significantly superior to AM in all assessed parameters other than operation duration. RALM and CLM performed similarly in most parameters; however, RALM was associated with reduced intra-operative bleeding in patients with small fibroids and had lower rates of conversion to laparotomy, proving RALM as a safer overall approach. Conclusion: The robotic approach for surgical treatment of uterine fibroids is a safe, effective, and viable approach, which is constantly being improved and may soon acquire widespread adoption and prove to be superior to CLM in certain patient subgroups.

16 June 2021 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
KPKonstantinos Perivoliotis
Konstantinos Perivoliotis
IBIoannis Baloyiannis
Ioannis Baloyiannis
DRDimitrios Ragias
Dimitrios Ragias
NBNikolaos Beis
Nikolaos Beis
DPDespoina Papageorgouli
Despoina Papageorgouli
KTKonstantinos Tepetes
Konstantinos Tepetes

5 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Dimitrios PapageorgiouDimitrios Papageorgiou
Dimitrios Papageorgiou
EZEleftherios Zachariou
Eleftherios Zachariou
ISIOAKEIM SAPANTZOGLOU
IOAKEIM SAPANTZOGLOU
ETElias Tsakos
Elias Tsakos
EXEmmanouil M. Xydias
Emmanouil M. Xydias
NPNikolaos Plevris
Nikolaos Plevris
Background/Objectives: Obesity is a well-established risk factor for endometrial cancer and presents challenges for surgical management. Robotic-assisted surgery offers a minimally invasive approach with potential benefits for obese patients. This study sought to assess the impact of body mass index (BMI) on surgical performance and short-term outcomes in patients undergoing robotic surgery for early-stage endometrial cancer, focusing on follow-up and perioperative treatment. Methods: A retrospective analysis was conducted on 54 patients with early-stage endometrial cancer who underwent a robotic total hysterectomy, bilateral salpingo-oophorectomy, and indocyanine green sentinel lymph node biopsy between January 2021 and December 2024 at two tertiary centers. Patients were stratified by body mass index. Surgical variables, sentinel lymph node detection rates, peri- and postoperative complications, length of hospital stay, and short-term oncologic outcomes were assessed. Statistical comparisons were performed using ANOVA, chi-square tests, and Pearson’s correlation analysis. Results: The mean patient age was 59.7 years, with a mean BMI of 31.1 kg/m2. Bilateral sentinel lymph node detection was successful in 87% of cases, with no significant differences between BMI groups. Console time, hospital stay, and complication rates were comparable across BMI categories. Console time positively correlated with the number of lymph nodes removed (r = 0.302, p = 0.026), but not with BMI. At a mean follow-up of 24.4 months, no recurrences were observed. Conclusions: Robotic surgery for early-stage endometrial cancer is safe and effective regardless of BMI, including in patients with Class III obesity. BMI does not negatively impact surgical or short-term oncologic outcomes, supporting robotic surgery as an optimal approach in obese endometrial cancer patients.

2 July 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
EXEmmanouil M. Xydias
Emmanouil M. Xydias
PLPolyxeni-Natalia Liasidi
Polyxeni-Natalia Liasidi
DPDespoina Papageorgouli
Despoina Papageorgouli
ETElias Tsakos
Elias Tsakos
NGNikolaos Gouliopoulos
Nikolaos Gouliopoulos
AZApostolos C. Ziogas
Apostolos C. Ziogas

2 September 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
EXEmmanouil M. Xydias
Emmanouil M. Xydias
VEVasileios Emmanouil
Vasileios Emmanouil
MKMaria Koutini
Maria Koutini
ANAnna Ntanika
Anna Ntanika
ETElias Tsakos
Elias Tsakos
Apostolos ZiogasApostolos Ziogas
Apostolos Ziogas
Background/Objectives: Tubal dysfunction may be a contributing factor in up to 35% of infertility cases, rendering tubal patency assessment a vital component of the infertility workup. In this review we examined the diagnostic efficacy and tolerability of hysterosalpingo-foam sonography (HyFoSy) and compared it to hysterosalpingography (HSG) and hysterosalpingo-contrast sonography (HyCoSy). Methods: Online databases were systematically searched and evaluated according to the PRISMA 2020 guidelines. Statistical heterogeneity was assessed. Diagnostic sensitivity, specificity and inter-method agreement were evaluated, along with mean pain scores. Results: This analysis included data from 9 studies and 1354 patients with conclusive diagnostic data from 2422 tubes and 1294 patients with data on intra-procedural pain. With regard to HyFoSy and HyCoSy comparison, pooled sensitivity was 87% and 69%, respectively (p = 0.074), while pooled specificity was 95% and 85%, respectively, favoring HyFoSy (p < 0.001). HyFoSy was more tolerable with regard to pain, but this was not statistically significant. Regarding the HyFoSy and HSG comparison, pooled Cohen’s k was 0.38, indicating fair-moderate agreement. In subsequent analysis, with HSG as a reference standard, HyFoSy demonstrated low sensitivity (61%) but high specificity (87%). With regard to experienced pain, HyFoSy and HSG had a difference of 2.4 units on a 10-point scale, favoring HyFoSy (p < 0.001). Conclusions: HyFoSy was superior to HyCoSy and may be used as a first-line tubal assessment method, with HSG being utilized in inconclusive cases. However, further research is still required due to the small number of available studies.

28 March 2023
Verified
Preprint
Open access
PDF file
ETElias Tsakos
Elias Tsakos
EXEmmanouil M. Xydias
Emmanouil M. Xydias
AZApostolos C. Ziogas
Apostolos C. Ziogas
FSFelice Sorrentino
Felice Sorrentino
LNLuigi Nappi
Luigi Nappi
ADAngelos Daniilidis
Angelos Daniilidis
Multi-port robotic assisted (Da Vinci) laparoscopic myomectomy: a systematic review and meta-analysis of comparative clinical and fertility outcomes.Elias Tsakos1,2, Emmanouil M. Xydias1,2,3, Apostolos C. Ziogas2,3, Felice Sorrentino4, Luigi Nappia4, Nikolaos Vlachos5, Aggelos Daniilidis61: EmbryoClinic IVF, Thessaloniki, Greece2: Hellenic medical Research Institute (HMRI), Thessaloniki, Greece3: University of Thessaly, School of Health Sciences, Faculty of Medicine, Larissa, Greece4: Institute of Obstetrics and Gynecology, University of Foggia, Italy5: National and Kapodistrial University of Athens, School of Medicine, Department of Obstetrics and Gynaecology6: Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, GreeceAbstract